PLSE - Pulse Biosciences Inc Stock Price, Fair Value and News

$13.48+0.49 (+3.77%)

Market Closed

Max Portfolio Pct.

Check

Valuation

Check

Stock Quality:

Max Portfolio Pct.

Check

Valuation

Check

PLSE Price Action

Last 7 days

-2.2%

Last 30 days

-19.7%

Last 90 days

-11.1%

Trailing 12 Months

-33.5%

PLSE RSI Chart

PLSE Valuation

Market Cap

913.5M

Price/Earnings (Trailing)

-12.22

Price/Sales (Trailing)

1.6K

EV/EBITDA

-12.11

Price/Free Cashflow

-18.73

PLSE Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

PLSE Fundamentals

PLSE Revenue

Revenue (TTM)

700.0K

Rev. Growth (Yr)

200%

Rev. Growth (Qtr)

20%

PLSE Earnings

Earnings (TTM)

-74.7M

Earnings Growth (Yr)

-52.88%

Earnings Growth (Qtr)

-1.13%

PLSE Profitability

Operating Margin

100.00%

EBT Margin

-9718.29%

Return on Equity

-80.62%

Return on Assets

-68.71%

Free Cashflow Yield

-5.34%

PLSE Investor Care

Shares Dilution (1Y)

10.16%

Revenue & Growth

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs

Net sales

Year	Q1	Q2	Q3	Q4
2025	0	0	0	0
2024	0	0	0	0
2022	1.9M	2.1M	1.6M	700.0K
2021	0	0	682.0K	1.4M
2020	0	607.0K	326.0K	0
2019	0	0	0	0

Get all data in R, Python etc through our Historical Stock Data APIs

About Pulse Biosciences Inc

Pulse Biosciences, Inc. operates as a novel bioelectric medicine company. It offers CellFX System, a tunable, software-enabled, and console-based platform that delivers nano second duration pulses of electrical energy to non-thermally clear targeted cells while sparing adjacent non-cellular tissue to treat a various medical condition by using its Nano-Pulse Stimulation technology. The company was formerly known as Electroblate, Inc. and changed its name to Pulse Biosciences, Inc. in December 2015. The company was incorporated in 2014 and is headquartered in Hayward, California.

WEBSITE	pulsebiosciences.com
SECTOR	Healthcare
INDUSTRY	Medical Instruments & Supplies
EMPLOYEES	61

Pulse Biosciences Inc Frequently Asked Questions

What is the ticker symbol for Pulse Biosciences Inc? What does PLSE stand for in stocks?

PLSE is the stock ticker symbol of Pulse Biosciences Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Pulse Biosciences Inc (PLSE)?

As of Wed Dec 03 2025, market cap of Pulse Biosciences Inc is 913.51 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PLSE stock?

You can check PLSE's fair value in chart for subscribers.

Is Pulse Biosciences Inc a good stock to buy?

The fair value guage provides a quick view whether PLSE is over valued or under valued. Whether Pulse Biosciences Inc is cheap or expensive depends on the assumptions which impact Pulse Biosciences Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PLSE.

What is Pulse Biosciences Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Wed Dec 03 2025, PLSE's PE ratio (Price to Earnings) is -12.22 and Price to Sales (PS) ratio is 1.58 Thousand. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PLSE PE ratio will change depending on the future growth rate expectations of investors.